Erning Cao is an Investment Director located in Shanghai, China and represents Evonik Venture Capital in the region Asia. He holds board representative seats at Meditool and Smart AHC.
Erning joined Evonik in 2008 as Regional Controller for Greater China. Thereafter he took responsibilities as Asia Controller for Evonik businesses and most recently, based in Darmstadt, headed global controlling for the Business Line Methacrylates. Prior to joining Evonik he worked 13 years in various finance and business administration functions for Alstom and Siemens rising to hold the position of CFO at two Siemens joint venture businesses in China. Erning studied Economics in Shanghai with a master degree on business administration.